| ·Dupixent(dupilumab)在美获批新适应症 | 2022-09-30 16:08:16 |
| ·再生元制药/赛诺菲治疗嗜酸细胞性食管炎dupilumab获美... | 2022-04-08 11:31:01 |
| ·赛诺菲特应性皮炎药度普利尤单抗获得批准 | 2020-06-19 11:09:37 |
| ·赛诺菲Dupilumab申请上市用于特应性皮炎 | 2019-12-26 11:49:04 |
| ·美批准Dupixent(dupilumab)用于慢性鼻窦炎 | 2019-06-28 11:00:00 |
| ·Dupilumab儿童甾体依赖性重度哮喘3期试验成功 | 2017-11-01 11:19:23 |
| ·欧盟批准Dupixent(dupilumab)用于特应性皮炎 | 2017-10-09 11:08:59 |
| ·Dupixent(dupilumab)哮喘3期试验达主要终点 | 2017-09-13 12:11:27 |
| ·美批准体Dupixent(dupilumab)用于特应性皮炎 | 2017-03-29 12:26:59 |
| ·Dupilumab审请用于特应性皮炎 | 2016-10-09 12:29:02 |
| ·Dupilumab特应性皮炎一项3期试验获肯定结果 | 2016-06-13 12:19:15 |
| ·Dupilumab开始持续性哮喘3期试验 | 2015-05-25 16:45:07 |
| ·Dupilumab异位性皮炎2b期试验结果发布 | 2015-03-26 15:18:31 |
| ·Dupilumab进行异位性皮炎3期试验 | 2014-10-21 11:32:25 |
| ·在研抗过敏药Dupilumab前景看好 | 2014-09-24 15:39:14 |
| ·Dupilumab异位性皮炎IIb期试验获肯定结果 | 2014-07-10 15:41:48 |
| ·Dupilumab进行过敏性哮喘2期试验 | 2013-05-23 14:30:55 |